<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02871856</url>
  </required_header>
  <id_info>
    <org_study_id>HREC/16/QPCH/181</org_study_id>
    <nct_id>NCT02871856</nct_id>
  </id_info>
  <brief_title>International Lung Screen Trial (ILST)</brief_title>
  <acronym>ILST</acronym>
  <official_title>International Lung Screen Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Queensland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Queensland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      People who may be at increased risk of lung cancer due to age and smoking history will be
      invited to participate in this international study to determine the best way of using
      computed tomography (CT) of the chest to screen for early lung cancer. Overseas data show
      that CT screening (screening tests can find diseases early, when they're easier to treat) can
      reduce deaths from lung cancer and this study will help determine who is most likely benefit
      from screening.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      [insert site name]
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2017</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of Lung cancers</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of nodules</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>5 Years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cancer detection rate</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Types and number of investigations</measure>
    <time_frame>5 Years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Non-small Cell Lung Cancer</condition>
  <condition>Lung Neoplasms</condition>
  <condition>Respiratory Tract Neoplasms</condition>
  <condition>Thoracic Neoplasms</condition>
  <condition>Neoplasms by Site</condition>
  <condition>Neoplasms</condition>
  <condition>Lung Diseases</condition>
  <condition>Respiratory Tract Diseases</condition>
  <condition>Smokers at Risk of Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Single</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single arm only, CT screening of lung</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Low dose CT</intervention_name>
    <description>low-dose screening CT of chest for lung cancer detection</description>
    <arm_group_label>Single</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Inclusion Criteria:

          -  Women or men age from 55 to 80.

          -  Current or former smokers. A former smoker is defined as one who has stopped smoking
             for one or more years.

          -  An estimated 6-year lung cancer risk of ≥1.51% based on the PLCOm2012 risk prediction
             model or ≥ 30 pack-years smoking history (pack-year is defined as number of pack of
             cigarettes smoked per day multiply by the number of years smoked. If a participant
             stopped smoking for 6 months or more and then restarted smoking again, the time will
             be subtracted from the total duration of smoking in 0.5 year increments)

          -  ECOG performance status 0 or 1.

          -  Capable of providing, informed consent for screening procedures (low dose spiral CT)

          -  Exclusion Criteria

          -  Clinical symptoms suspicious for lung cancer e.g. hemoptysis, chest pain, weight loss

          -  Any medical condition, such as severe heart disease (e.g. unstable angina, chronic
             congestive heart failure), acute or chronic respiratory failure, home oxygen therapy,
             bleeding disorder, that in the opinion of the investigator could jeopardize the
             subject's safety during participation in the study or unlikely to benefit from
             screening due to shortened life-expectancy from the co-morbidities

          -  Have been previously diagnosed with lung cancer

          -  Have had other non-curatively treated cancer outside the lung.

          -  Pregnancy

          -  Pneumonia or bronchitis requiring antibiotic treatment within the last 12 weeks

          -  Unwilling to have a spiral chest CT

          -  Chest CT within 2 years

          -  Does not fit into CT scanner table due to gross obesity

          -  Cannot lie on CT scanning table on the back with arms over the head

          -  Received chemotherapy or cytotoxic drugs within the last 6 months

          -  Unwilling to sign a consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kwun M Fong</last_name>
    <role>Principal Investigator</role>
    <affiliation>UQTRC at TPCH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Lam</last_name>
    <role>Principal Investigator</role>
    <affiliation>British Columbia Cancer Agency</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kwun M Fong</last_name>
    <phone>+ 61 7 31394111</phone>
    <email>lungscreen@health.qld.gov.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Henry M Marshall</last_name>
    <phone>+ 61 7 31394111</phone>
    <email>lungscreen@health.qld.gov.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Vincent's Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Kent</last_name>
      <phone>0293555611</phone>
      <email>SVHS.CancerResearch@svha.org.au</email>
    </contact>
    <investigator>
      <last_name>Emily Stone</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Prince Charles Hospital</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4032</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Passmore</last_name>
      <phone>0731396632</phone>
      <email>Lungscreen@health.qld.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Liz McCaul</last_name>
      <phone>0731396632</phone>
      <email>Lungscreen@health.qld.gov.au</email>
    </contact_backup>
    <investigator>
      <last_name>Kwun Fong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelley Mesfin</last_name>
      <phone>03 93424707</phone>
      <email>RMH-Lungscreening@mh.org.au</email>
    </contact>
    <contact_backup>
      <last_name>Stewart Duncum</last_name>
      <phone>03 93424707</phone>
      <email>RMH-Lungscreening@mh.org.au</email>
    </contact_backup>
    <investigator>
      <last_name>Renee Manser</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Logan</last_name>
      <phone>0861511238</phone>
      <email>FSH.InternationalLungScreenTrial@health.wa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Fraser Brims</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Logan</last_name>
      <phone>0861511238</phone>
      <email>FSH.InternationalLungScreenTrial@health.wa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Annette McWilliams</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BC Cancer Research Centre</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z1L3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sukhinder Atkar-Khattra</last_name>
      <phone>1-604-675-8000</phone>
      <phone_ext>7095</phone_ext>
      <email>Bclungscreening2015@gmail.com</email>
    </contact>
    <contact_backup>
      <phone>1-604-675-8094</phone>
    </contact_backup>
    <investigator>
      <last_name>Stephen Lam</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2016</study_first_submitted>
  <study_first_submitted_qc>August 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2016</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Queensland</investigator_affiliation>
    <investigator_full_name>Kwun Fong</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Screening</keyword>
  <keyword>Computed tomography</keyword>
  <keyword>Lung cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
    <mesh_term>Neoplasms by Site</mesh_term>
    <mesh_term>Thoracic Neoplasms</mesh_term>
    <mesh_term>Respiratory Tract Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

